
Encompass Health (EHC) stock: analyst price target and their real reliability
📈 Encompass Health (EHC) stock price
🎯 EHC price target & analyst consensus — price $120
⭐ The most reliable of them, either direction: Truist Securities — 64% of its targets hit on this sector (109 calls tested). It aims for $150 (+25 %), call made on August 8, 2026, maturing on August 8, 2027 (20 d ago).
All 62 calls, one by one, with our verdict on each firm.
→ See all 62 targets, analyst by analystTheir real reliability on EHC, firm by firm: who was right, who was wrong.
→ See their reliability on EHC💰 Encompass Health dividend: yield, history & growth › open the full page
📈 Encompass Health fundamentals: valuation, margins & growth › open the full page
Revenue, net income and margin per year
✅ Historical analyst reliability on EHC
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Mizuho ↗ | 100% | +21.2% | 8 |
| Jefferies ↗ | 100% | +15.9% | 2 |
| B of A Securities ↗ | 100% | +15.9% | 2 |
| Stephens & Co. ↗ | 91% | +23.7% | 11 |
| RBC Capital ↗ | 85% | +21.7% | 13 |
| Truist Securities ↗ | 83% | +21.2% | 12 |
| Barclays ↗ | 82% | +20.4% | 11 |
| Raymond James ↗ | 73% | +13.1% | 15 |
| Credit Suisse | 73% | +11.8% | 15 |
| BMO Capital ↗ | 67% | +12.8% | 3 |
📊 What $1,000 invested in Encompass Health would be worth › open the full page
If I'd invested $1,000 in Encompass Health
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,009 | +1% |
| 3 years ago | $1,788 | +79% |
| 5 years ago | $1,580 | +58% |
Return by year (Encompass Health)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -6% | $937 (-6%) |
| 2025 | +8% | $1,009 (+1%) |
| 2024 | +35% | $1,359 (+36%) |
📰 Recent news on Encompass Health
📋 All analyst calls on EHC
matures : Aug 10, 27
matures : Aug 8, 27
matures : Aug 7, 27
matures : Aug 6, 27
matures : May 28, 27
matures : May 5, 27
matures : Feb 6, 27
matures : Oct 30, 26
See the other 54 calls, newest to oldest
matures : Oct 2, 26
matures : Sep 16, 26
matures : Sep 10, 26
Frequently asked questions
Should I buy Encompass Health stock?
This isn't buy advice. For Encompass Health, the analyst consensus is "Buy", with an average price target of $147 (+23% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (8 calls tracked on Encompass Health). We show the numbers — you decide.
Is it too late to buy Encompass Health? How high can it go?
The most bullish analyst target on Encompass Health is $155 (+30% above today's price); the average is $147. That's the upside they see. Check how reliable those analysts have actually been on Encompass Health on our site before trusting it.
Is Encompass Health still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 13 analysts have a real record on Encompass Health, the best hitting 100% over 8 calls. Current consensus: "Buy". Make your call on data, not noise.
What has Encompass Health's past performance been?
Historical returns and a "how much if I had invested" calculator: EHC performance & returns.
Does Encompass Health pay a dividend?
Yield, consistency and growth history of the dividend: EHC's dividend.
What is the best month to buy EHC?
The 12 months ranked by the stock's past returns: best & worst month to buy EHC.